Shalini Sharp - Jun 7, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Shalini Sharp
Stock symbol
OGN
Transactions as of
Jun 7, 2024
Transactions value $
$200,000
Form type
4
Date filed
6/11/2024, 03:17 PM
Previous filing
May 23, 2024
Next filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Phantom Stock Award $200K +9.64K +35.51% $20.75 36.8K Jun 7, 2024 Common Stock 9.64K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2 Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3 Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.